Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation. Read more about Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation.
Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report. Read more about Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report.
Feasibility of a PB CD34+ cell transplantation procedure using standard leukapheresis products in very small children. Read more about Feasibility of a PB CD34+ cell transplantation procedure using standard leukapheresis products in very small children.
Cognitive and adaptive behavior 1 and 3 years following bone marrow transplantation. Read more about Cognitive and adaptive behavior 1 and 3 years following bone marrow transplantation.
Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma. Read more about Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.
High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study. Read more about High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study.
Long-term engraftment following in utero T cell-depleted parental marrow transplantation into fetal rhesus monkeys. Read more about Long-term engraftment following in utero T cell-depleted parental marrow transplantation into fetal rhesus monkeys.
Haploidentical bone marrow transplants for two patients with reticular dysgenesis. Read more about Haploidentical bone marrow transplants for two patients with reticular dysgenesis.
Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia. Read more about Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.
